Boltjes Arjan, van Montfoort Nadine, Biesta Paula J, Op den Brouw Marjoleine L, Kwekkeboom Jaap, van der Laan Luc J W, Janssen Harry L A, Boonstra André, Woltman Andrea M
Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands Division of Gastroenterology, Liver Clinic University Health Network, University of Toronto, Ontario, Canada.
J Infect Dis. 2015 Apr 15;211(8):1268-78. doi: 10.1093/infdis/jiu599. Epub 2014 Oct 31.
Based on their localization, Kupffer cells (KCs) likely interact with hepatitis B virus (HBV). However, the role of KCs in inducing immunity toward HBV is poorly understood. Therefore, the interaction of hepatitis B surface antigen (HBsAg) and KCs, and possible functional consequences, were assessed.
KCs in liver tissue from patients with chronic HBV were analyzed for presence of HBsAg and their phenotype, and compared with KCs in control liver tissue. Liver graft perfusate-derived KCs and in vitro-generated monocyte-derived macrophages were investigated for functional interaction with patient-derived HBsAg.
Intrahepatic KCs were HBsAg positive and more activated than those from control livers. KCs internalized HBsAg in vitro, which did not change their phenotype, but strongly induced proinflammatory cytokine production. Additionally, monocyte-derived macrophages also interacted with HBsAg, leading to activation and cytokine production. Furthermore, HBsAg-exposed macrophages and KC activated natural killer (NK) cells, resulting in increased CD69 expression and interferon-γ production.
KCs directly interact with HBsAg in vivo and in vitro. HBsAg-induced cytokine production by KCs and monocyte-derived macrophages and subsequent NK cell activation may be an early event in viral containment and may support induction of HBV-specific immunity upon HBV infection, but may also contribute to liver pathology.
基于其定位,库普弗细胞(KCs)可能与乙型肝炎病毒(HBV)相互作用。然而,KCs在诱导针对HBV的免疫反应中的作用尚不清楚。因此,评估了乙型肝炎表面抗原(HBsAg)与KCs的相互作用及其可能的功能后果。
分析慢性HBV患者肝组织中的KCs是否存在HBsAg及其表型,并与对照肝组织中的KCs进行比较。研究了肝移植灌注液来源的KCs和体外产生的单核细胞衍生巨噬细胞与患者来源的HBsAg的功能相互作用。
肝内KCs呈HBsAg阳性,且比对照肝脏中的KCs更具活性。KCs在体外内化HBsAg,这并未改变其表型,但强烈诱导促炎细胞因子的产生。此外,单核细胞衍生巨噬细胞也与HBsAg相互作用,导致其活化和细胞因子产生。此外,暴露于HBsAg的巨噬细胞和KCs激活自然杀伤(NK)细胞,导致CD69表达增加和干扰素-γ产生。
KCs在体内和体外均直接与HBsAg相互作用。HBsAg诱导KCs和单核细胞衍生巨噬细胞产生细胞因子以及随后的NK细胞活化可能是病毒控制的早期事件,可能支持HBV感染后诱导HBV特异性免疫,但也可能导致肝脏病理变化。